Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide pens contain 2.4 mg of active medication delivered through a series of weekly injections that begin at 0.25 mg and typically escalate over four months. Understanding how your pen works, what dose progression looks like, and how PlexusDx supports your treatment can help you feel confident throughout your weight loss therapy.
How Many Doses Are in a Semaglutide Pen?
A standard semaglutide pen holds enough medication for four weekly injections at a single dose strength. Because treatment involves stepping up your dose over time, most people using branded Wegovy receive multiple pens throughout their first four months of therapy. The typical progression includes four separate pens: one for the 0.25 mg dose week, one for 0.5 mg, one for 1 mg, and one for 1.7 mg or higher maintenance doses.
PlexusDx compounded semaglutide injections follow the same evidence-based dose escalation pattern to help your body adapt to the medication while minimizing side effects. Your licensed 503A compounding pharmacy prepares each dose to pharmaceutical standards, and your monthly price remains flat regardless of which dose level you're taking. This means your dose may increase as you progress through treatment, but your cost won't.
Understanding the Four-Week Dose Escalation Schedule
Week 1 through week 4 of semaglutide treatment starts with the lowest dose of 0.25 mg injected once weekly. This introductory phase allows your GLP-1 receptors—the nerve endings that signal fullness and regulate hunger—to begin responding to the medication without overwhelming your system. Most patients tolerate this starting dose well, though some experience mild nausea that typically resolves within days.
Weeks 5 through 8 increase your dose to 0.5 mg weekly, and weeks 9 through 12 move to 1 mg. By weeks 13 through 16, you typically reach 1.7 mg, which is considered the standard maintenance dose for weight loss in clinical trials. Some individuals benefit from doses up to 2.4 mg, the maximum amount available in a single pen. Your healthcare provider adjusts your schedule based on your response, tolerability, and weight loss goals.
What to Expect During Your Semaglutide Treatment Journey
Most patients notice reduced appetite within the first two weeks of starting semaglutide, often describing food as less appealing or feeling full after smaller portions. Weight loss typically becomes noticeable around week four, with an average loss of 1 to 2 pounds per week during the initial months. By week 16, many people report losing 5 to 10 pounds as the medication reaches its therapeutic dose.
Common side effects include mild to moderate nausea, constipation, and occasional fatigue, particularly during the early weeks. These effects usually improve as your body adapts and your dosing stabilizes. Staying hydrated, eating small frequent meals, and adjusting your diet to include more fiber can reduce digestive discomfort. PlexusDx provides detailed guidance on managing side effects and optimizing your results throughout treatment.
By month four and beyond, most people reach a stable maintenance dose where hunger stays suppressed and weight loss continues at a steady pace. Many patients experience sustained weight loss of 15 to 22 percent of their body weight after six months of consistent use, according to clinical trial data from the STEP program.
PlexusDx Compounded Semaglutide vs. Branded Pens
PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies, which manufacture the medication under the same quality standards as commercial versions but at a significantly lower cost. Your compounded injection contains the same active pharmaceutical ingredient (semaglutide) as branded Wegovy, prepared specifically for your treatment plan. Compounded medications are not FDA-approved as finished products, but the active ingredient and manufacturing processes meet strict pharmacy board regulations across all 50 states.
PlexusDx semaglutide injections start at $149 per month with a flat price structure—your dose can increase without your monthly cost changing. This pricing model removes the financial barrier many patients face when managing long-term weight loss therapy. Combined with HSA/FSA eligibility and no membership fees or insurance requirements, PlexusDx makes sustained semaglutide treatment accessible to more people seeking personalized weight loss solutions.
Genetic Testing and Personalized Dose Optimization
PlexusDx offers the Precision Peptide Genetic Test, a $99 add-on available after your first month of treatment that maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights. This test examines key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313—genetic markers that influence how your body responds to GLP-1 medications. Understanding your genetic predispositions helps your healthcare provider refine your dose and potentially combine semaglutide with complementary treatments for maximum results.
Your genetic profile can reveal whether you're a strong responder to semaglutide, a moderate responder, or whether you might benefit from additional peptide therapy alongside your GLP-1 treatment. This personalized approach transforms weight loss from a one-size-fits-all strategy into a precision medicine plan tailored to your unique biology. PlexusDx uses your test results to optimize your monthly treatment plan and adjust recommendations as your body evolves.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many injections do I give myself each week on semaglutide?
You inject once per week, every seven days, using the same pen for four consecutive weeks before moving to your next dose level. Most patients inject on the same day each week for consistency. PlexusDx provides clear instructions and support to ensure you feel confident administering your weekly injection at home.
Will I need to use multiple pens during my first month of treatment?
No, your first month uses only one pen containing enough medication for four weekly 0.25 mg injections. Subsequent months introduce new pens as your dose increases, but PlexusDx coordinates your pharmacy delivery to align with your dose schedule. This eliminates confusion and ensures you always have the correct dose ready when you need it.
Can I stay on semaglutide long-term, or is it only for a few months?
Semaglutide can be used for extended periods once you reach your maintenance dose, with many patients continuing for months or years to sustain weight loss. Clinical evidence shows that stopping semaglutide often leads to weight regain, so ongoing treatment is recommended for sustained results. PlexusDx supports continuous therapy with consistent flat pricing at $149 per month, making long-term treatment affordable.
What happens if semaglutide side effects are too strong?
Your healthcare provider can pause your dose increase, stay at your current level longer, or lower your dose if nausea or other effects become unbearable. Most side effects resolve within days to weeks as your body adapts. PlexusDx monitors your progress closely and adjusts your treatment plan to balance efficacy with tolerability throughout your journey.
How does the Precision Peptide Genetic Test help optimize my semaglutide dose?
The test reveals genetic variants that influence your GLP-1 receptor sensitivity and metabolic response to semaglutide, helping your provider determine whether you'll respond best to standard dosing or whether you might benefit from higher doses or combination therapy. For example, specific GLP1R variants correlate with stronger appetite suppression at lower doses, potentially allowing you to achieve results faster. This personalized insight transforms guesswork into data-driven precision dosing.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Ozempic A Weight Loss Solution? Exploring Its Role in Weight Management
Ozempic Pen: Understanding Stability and When You Can Use It After Opening